Blood Brain Barrier Disruption (BBBD) Using MRgFUS in the Treatment of Her2-positive Breast Cancer Brain Metastases

Clinical trial NCT03714243 · COMPLETED

Trial details

NCT number: NCT03714243
Sponsor: InSightec
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Breast Cancer Brain Metastases

Start date: 2019-09-18
Primary completion: 2022-04-28
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.